ABSTRACT. A combination of pancreatic insufficiency and inadequate caloric intake may produce essential fatty acid (EFA) deficiency in patients with cystic fibrosis. Seventy-five percent of the adolescents and young adults with poor weight gain in our clinic were EFA-deficient by total plasma linoleic acid criteria. Twenty of these patients were placed on an oral hyperalimentation regimen containing 230 % of calories required for basal energy expenditure, 40 % as fat. Forty percent of these (8/20) achieved normal EFA levels on this diet. Eight of the nonresponding patients were given an additional 5 % of their caloric intake as linoleic acid monoglyceride. All who main-tained caloric intake achieved normal EFA levels. Normaliza-tion of EFA ...
Fat malabsorption in pancreatic insufficient cystic fibrosis (CF) patients is classically treated wi...
Objective: To assess the relationship between dietary intakes, plasma phospholipid (PL) fatty acid p...
Cystic fibrosis is an inherited multi-organ disorder caused by mutations in the CFTR gene. Patients ...
Essential fatty acid deficiency is well known in cystic fibrosis patients, but its pathogenesis rema...
Essential fatty acid deficiency is well known in cystic fibrosis patients, but its pathogenesis rema...
Adequate intake of nutrients such as essential fatty acids (EFA) are critical in cystic fibrosis (CF...
Essential fatty acid deficiency has been increasingly reported in patients with cystic fibrosis. The...
Affiliation: CHU-Sainte-Justine, Université de MontréalTransport mechanisms, whereby alimentary lipi...
SEVERAL CLINICAL OBSERVATIONS suggest that changes in a fatty acid concentration are associated with...
* FEV, forced expired volume ml BTPS; MEF25-75%, Average maxi-mum expiratory flow during mid-50 % of...
BACKGROUND: Some but not all studies have reported abnormal polyunsaturated fatty acid composition i...
Background: Pancreatic enzyme replacement therapy frequently fails to correct intestinal fat malabso...
ABSTRACT. Background: Supplementation of the diet with eicosapentaenoic acid and docosahexaenoic aci...
We studied the effects of supplementing patients with cystic fibrosis for 1 month with 3 g/day of a ...
OBJECTIVE: To assess the relationship between dietary intakes, plasma phospholipid (PL) fatty acid p...
Fat malabsorption in pancreatic insufficient cystic fibrosis (CF) patients is classically treated wi...
Objective: To assess the relationship between dietary intakes, plasma phospholipid (PL) fatty acid p...
Cystic fibrosis is an inherited multi-organ disorder caused by mutations in the CFTR gene. Patients ...
Essential fatty acid deficiency is well known in cystic fibrosis patients, but its pathogenesis rema...
Essential fatty acid deficiency is well known in cystic fibrosis patients, but its pathogenesis rema...
Adequate intake of nutrients such as essential fatty acids (EFA) are critical in cystic fibrosis (CF...
Essential fatty acid deficiency has been increasingly reported in patients with cystic fibrosis. The...
Affiliation: CHU-Sainte-Justine, Université de MontréalTransport mechanisms, whereby alimentary lipi...
SEVERAL CLINICAL OBSERVATIONS suggest that changes in a fatty acid concentration are associated with...
* FEV, forced expired volume ml BTPS; MEF25-75%, Average maxi-mum expiratory flow during mid-50 % of...
BACKGROUND: Some but not all studies have reported abnormal polyunsaturated fatty acid composition i...
Background: Pancreatic enzyme replacement therapy frequently fails to correct intestinal fat malabso...
ABSTRACT. Background: Supplementation of the diet with eicosapentaenoic acid and docosahexaenoic aci...
We studied the effects of supplementing patients with cystic fibrosis for 1 month with 3 g/day of a ...
OBJECTIVE: To assess the relationship between dietary intakes, plasma phospholipid (PL) fatty acid p...
Fat malabsorption in pancreatic insufficient cystic fibrosis (CF) patients is classically treated wi...
Objective: To assess the relationship between dietary intakes, plasma phospholipid (PL) fatty acid p...
Cystic fibrosis is an inherited multi-organ disorder caused by mutations in the CFTR gene. Patients ...